Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label propranolol study in infants with proliferating infantile hemangioma requiring systemic therapy
2010-023488-16Phase 3Completed
- Sponsor
- Pierre Fabre Dermatologie
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of propranolol in Capillary Haemangioma, sponsored by Pierre Fabre Dermatologie. Primary endpoints: Safety profile of propranolol and Effect on resolution of target proliferating infantile hemangioma. Started Dec 2010; status: completed.
02
Drugs
propranolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on 2010-023488-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023488-16.